Procter & Gamble stock sits in an interesting spot right now. The Discounted Cash Flow (DCF) intrinsic value estimate points to a sizeable valuation gap, while the broader checks still flag only a mixed picture and the share price has delivered relatively modest gains over five years.

• Over the past 5 years, Procter & Gamble has returned 15.4%, which is a steady result rather than a runaway winner for long term holders.
• The planned US$3.8b acquisition of supplement brand Thorne may support expectations for stronger growth in premium wellness, while restructuring plans and job cuts highlight execution and cost risks that could affect future cash flows.
• The company screens as undervalued on both the Discounted Cash Flow (DCF) estimate and earnings multiples, yet its 4 out of 6 value score still points to a mixed picture rather than a clear-cut bargain.

The issue now is whether Procter & Gamble's current share price around US$145.79 still leaves enough upside relative to its intrinsic value estimate to appeal to valuation focused investors.

Is Procter & Gamble a Bargain on Cash Flow?

The Discounted Cash Flow (DCF) model estimates what Procter & Gamble is worth based on the cash it can return to shareholders over time. In this model, the company is treated as a mature business with growing free cash flow rather than a high growth story.

Procter & Gamble generated around $15.6b in free cash flow over the latest twelve months, and the cash flow projections used in the DCF assume that this base continues to grow. That produces an estimated intrinsic value of about $199 per share compared with the current share price near $145.79, which implies the stock screens around 26.8% undervalued on this method. The planned US$3.8b Thorne acquisition is one factor that may help explain why the market is still questioning how much of that future cash flow growth will actually be delivered.

Overall, the cash flow based valuation suggests Procter & Gamble stock appears undervalued at recent prices on this measure.

Our Discounted Cash Flow (DCF) analysis suggests Procter & Gamble is undervalued by 26.8%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Is Procter & Gamble Still Cheap on Earnings?

P/E is a useful check for Procter & Gamble because earnings are a key focus for a mature consumer staples business with established brands and cash flows.

The stock currently trades on a P/E of about 21.5x. That sits above the Household Products industry average of roughly 16.9x, yet it is below the broader peer group average of about 28.2x. A tailored fair P/E of around 26.0x, which reflects Procter & Gamble's size, margins and risk profile, is higher than where the shares trade today. This gap suggests that the market price does not fully reflect the level of earnings the model would imply for a company of this profile.

On the P/E multiple, Procter & Gamble stock appears undervalued relative to the earnings level implied by its fair ratio benchmark.

The Procter & Gamble Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Procter & Gamble pick up where this valuation puzzle leaves off and explain which assumptions about Procter & Gamble's future growth, margins and earnings would need to hold for the stock to be worth materially more or materially less than today's price on the Community page. Each narrative frames fair value as a thesis about the business that you can monitor over time rather than treating it as a static number.

Community views on Procter & Gamble sit far apart, with some investors seeing a resilient compounder and others focused on valuation risk.

Bull case: roughly fairly valued

"The company maintains a powerful stable of global brands... non-food consumer staples with strong brand loyalty and frequent repeat purchases..."

Bear case: 20% overvalued

"As you can see from the above Procter & Gamble seems to be overvalued given that its current price of 150.15 dollars is well above P90..."

Do you think there's more to the story for Procter & Gamble? Head over to our Community to see what others are saying!

The Bottom Line

For Procter & Gamble, both the Discounted Cash Flow (DCF) intrinsic value estimate and the earnings multiple view point to an undervalued stock, although broader checks still argue for some caution rather than a clear green light. The key judgement is whether future cash flows and margins hold up well enough for that estimated discount to close over time. With ongoing restructuring and the Thorne acquisition in the mix, the crux of the debate is whether current risks justify the discount or whether the market is underpricing a steady, cash generative consumer staples business.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.